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It has been proposed that the cytoplasmic SecB protein functions as a component of the Escherichia coli
protein export machinery by serving as an antifolding factor that retards folding of the precursor maltose-
binding protein (preMBP) into a translocation-incompetent form. In this study, it was found that SecB directly
interacts with wild-type preMBP and various mutationally altered MBP species synthesized in vitro to form a
SecB-MBP complex that can be precipitated with anti-SecB serum. The association of SecB with wild-type
preMBP was relatively unstable; such a complex was formed only when SecB was present cotranslationally or
after denaturation of previously synthesized preMBP and was detected with only low efficiency. In marked
contrast, MBP species that were defective in the ability to assume the stable conformation of wild-type preMBP
or that exhibited significantly slower folding kinetics formed much more stable complexes with SecB. In one
case, we demonstrated that SecB did not need to be present cotranslationally for complex formation to occur.
Formation of a complex between SecB and MBP was clearly not dependent on the MBP signal peptide.
However, we were unable to detect complex formation between SecB and MBP lacking virtually the entire
signal peptide but having a completely intact mature moiety. This MBP species folded at a rate considerably
faster than that of wild-type preMBP. The propensity of this mutant protein to assume the native conformation
of mature MBP apparently precludes a stable association with SecB, whereas an MBP species lacking a signal
peptide but exhibiting altered folding properties did form a complex with SecB that could be precipitated with
anti-SecB serum.
Translocation of proteins across bacterial, endoplasmic
reticulum, and mitochondrial membranes requires that the
newly synthesized polypeptide exhibit a translocation-com-
petent conformation that is thought to represent a largely
unfolded or loosely folded state (for recent reviews, see
references 1, 26, and 29). For proteins whose translocation is
not tightly coupled to translation, it has been proposed that
cytosolic activities capable of unfolding or retarding the
folding of proteins render the polypeptides competent for
translocation (1, 4-6, 8-11). In a previous study of protein
export in the bacterium Escherichia coli, Randall and Hardy
(28) correlated the folding of precursor maltose-binding
protein (preMBP) in the cytoplasm into a stable, tertiary
structure with the loss of export competence. Subsequently,
we presented biochemical and genetic evidence that the
cytoplasmic SecB protein functions as a component of the E.
coli export machinery by acting as an antifolding factor that
interacts with certain precursor proteins to retard their
folding prior to export from the cytoplasm (5, 6, 35). SecB is
thought to be one of a class of cytoplasmic proteins, called
chaperones (13), that can serve to maintain the export
competence of precursor polypeptides in E. coli. Other
proteins postulated to have a similar function include the
trigger factor characterized by Crooke et al. (8-10) and
GroEL (2).
SecB is a nonessential, tetrameric protein composed of
identical 16.4-kilodalton subunits that is required for the
efficient export of a subset of E. coli envelope proteins,
including the MBP (5, 19, 20, 21, 35). In cells lacking SecB,
MBP export appears to represent a race between delivery of
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the newly synthesized, export-competent polypeptide to the
export machinery in the cytoplasmic membrane and folding
of preMBP in the cytoplasm into an export-incompetent
conformation (5, 22, 28, 35). Purified SecB protein retards
folding of preMBP and can prolong the time in which
preMBP remains competent for posttranslational import into
membrane vesicles in vitro (35). The nature of the SecB-
MBP interaction in maintaining preMBP export competence
is not known. We had originally proposed that SecB bound
directly to the mature moiety of the newly synthesized
preMBP (5). Very recently, three different studies have
demonstrated that SecB directly associates in a 1:1 molar
ratio with several different precursor proteins, including
preMBP, preLamB, proOmpA, and prePhoE, to form a
soluble complex that presumably represents a transient
intermediate in the export process (18, 23, 32). In marked
contrast to our previous proposal, Watanabe and Blobel (33)
recently presented evidence indicating that SecB binds spe-
cifically to the emerging signal peptide of newly synthesized
preMBP. It was suggested that SecB functions as the pro-
caryotic equivalent of the signal recognition particle previ-
ously identified in studies of protein targeting to the rough
endoplasmic reticulum of eucaryotic cells (for a review, see
reference 30).
We have further investigated the interaction of SecB with
preMBP. Our studies indicate that the association of these
two proteins to form a complex is not dependent on the
signal peptide but is strongly influenced by the folding
properties of the mature MBP moiety.
MATERIALS AND METHODS
In vitro MBP synthesis. MBP was synthesized in vitro by
using a coupled E. coli transcription-translation system and
plasmid templates in which the malE alleles were under
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TABLE 1. MBP species tested for the ability to interact with SecB
MBP species Encoded by Mutational alteration competent? Reference
MBPspecies plasmid: competen Rfernc
MBP+ pJF2 Wild type: 26-residue signal peptide and 370-residue mature moiety Yes 15
MBPA323 pJF32 Deleted from residue 7 of signal peptide through residue 89 of mature moiety No 5
MBP2261 pJW13 Asp substituted for Tyr at residue 283 of mature protein Yes 34
MBPA&57-145 pDNC155 Deleted for residues 57 through 145 of mature moiety Yes 5
MBPA2-26 pUZ226 Deleted for residues 2 through 26 of signal peptide No 34
MBPA2-26/2261 pJW41 MBPA2-26 signal peptide and MBP2261 mature moiety No This study
transcriptional control of the lacUVS promoter-operator, as
described previously (5, 34, 35). Plasmids pDNC155
(MBPA57-145), pJF2 (wild-type MBP), pJF32 (MBPA323),
pJW13 (MBP2261), and pUZ226 (MBPA2-26) were de-
scribed previously (5, 15, 34). Plasmid pJW41 (MBPA2-
26/2261) was constructed by ligating the small EcoRI-BgIIH
fragment of plJZ226 (containing the 5' end of the malE gene
with the signal peptide coding region deleted) with the large
EcoRI-BglII fragment of pJWl3 (containing the malE2261
mutation). The MBP species encoded by these various
plasmids are described in Table 1. Plasmid pAI12, a deriva-
tive of pACYC encoding wild-type ribose-binding protein
(17), was provided by Linda Randall. Reaction components
were prepared from haploid secB+ cells (strain MC4100 [3]),
SecB-overproducing cells (strain MC4100 pDC2 [20]), and
SecB- cells (strain CK1953 [20]). The preparation of purified
SecB from SecB-overproducing cells has been described
previously (35).
Radioimmunoprecipitation reactions. The radiolabeled
translation reaction products were immediately diluted 50-
fold into buffer containing 50 mM Tris hydrochloride (pH
8.0), 150 mM NaCl, 0.1 mM EDTA, 2% Triton X-100, and
either preimmune rabbit serum, polyclonal rabbit anti-SecB
serum (35), or polyclonal rabbit anti-MBP serum (14). The
mixtures were incubated for 16 h at 4°C with mixing. The
immune complexes were precipitated with IgGsorb (Enzyme
Center, Boston, Mass.) and analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
autoradiography using 10% polyacrylamide gels, as de-
scribed previously (14). The amount ofMBP immunoprecip-
itated with anti-SecB serum was quantitated by counting the
radioactivity eluted from gel slices (5) and then calculated
relative to the amount of MBP immunoprecipitated with
anti-MBP serum. It should be noted that for unknown
reasons, radioimmunoprecipitation reactions using extracts
prepared from in vitro translation reactions -tend to give
significantly higher background levels than do similar reac-
tions using extracts prepared from whole cells. In quantitat-
ing the immunoprecipitation of proteins by immune serum,
the amount of the same protein precipitated by preimmune
serum was first subtracted. Hence, because of the higher
background levels, this calculation probably underestimated
to some degree the amount of protein that was specifically
precipitated.
RESULTS
MBP synthesized in vitro can be precipitated with anti-SecB
serum. Wild-type preMBP (preMBP+) and various mutant
MBP species were synthesized in an E. ccli coupled tran-
scription-translation system, using an S-100 fraction pre-
pared from SecB-overproducing cells. Membranes were not
present in the reaction mixture. Extracts containing the in
vitro reaction products were prepared and used in an immu-
noprecipitation reaction with preimmune rabbit serum or
rabbit anti-SecB or anti-MBP serum (see Materials and
Methods); The precipitates obtained were then analyzed by
SDS-PAGE and autoradiography (Fig. 1A) A small but still
significant amount (7%) ofpreMBP+ was specifically precip-
itated by the anti-SecB serum as compared with the amount
precipitated by anti-MBP serum. In marked contrast, an
internally truncated MBP species designated MBPA323 (Ta-
ble 1) was much more efficiently immunoprecipitated by
anti-SecB serum (42%). When SecB was omitted from the in
vitro reaction by using an S-100 fraction prepared from
SecB- cells, specific immunoprecipitation of MBPA323 with
anti-SecB serum was not observed (Fig. 1B). In addition,
when the precipitation of MBPA323 was performed in the
presence of an excess of purified SecB, the amount of
radiolabeled MBP precipitated was greatly reduced (Fig.
1B). These latter two experiments established that the pre-
cipitation ofMBP by anti-SecB serum was dependent on the
SecB protein.
We considered it likely that the more efficient precipitation
of MBPA323 by anti-SecB serum compared with preMBP+
was related to the folding properties of these two MBP
species (see Discussion). The role of folding in the ability of
MBP to form a stable complex with SecB was further
investigated by use of additional MBP species with altered
folding properties. MBP2261 has a single amino acid substi-
tution at residue 283 of the mature protein. Liu et al. (24)
have demonstrated that purified mMBP2261 refolds after
denaturation at a rate significantly slower than that of
wild-type mature MBP. A substantial proportion (32%) of
preMBP2261 synthesized in vitro was specifically immuno-
precipitated with anti-SecB serum (Fig. 1A). MBPA57-145,
missing residues 57 to 145 from the mature MBP, is unable to
assume the stable, tertiary conformation of MBP+ and
exhibits other properties indicating that its folding is signif-
icantly altered compared with that of MBP+ (5, 7, 24; see
Discussion). Precursor MBPA57-145 also was more effi-
ciently precipitated by anti-SecB serum that was preMBP+
(Fig. 1A).
Since MBPA323 is missing virtually the entire signal
peptide, the efficient formation of a stable complex between
this MBP species and SecB suggested that SecB specifically
interacts with the mature moiety ofMBP, as suggested in our
earlier study (5). Thus, we further assessed the role of the
signal peptide in formation of the stable SecB-MBP complex
through use of two MBP species that lack the entire 26-
residue signal peptide but contain either the intact mature
moiety (MBPA2-26) or the mature moiety containing the
same single amino acid substitution as does MBP2261
(MBPA2-26/2261). MBPA2-26 synthesized in vitro was un-
able to form a stable complex with SecB under the experi-
mental conditions used, as demonstrated by the failure to
specifically immunoprecipitate this protein (less than 1%)
with anti-SecB serum (Fig. 1A). In marked contrast, large
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FIG. 1. SecB-MBP complex formation obtained by using an S-100 fraction prepared from SecB-overproducing cells. (A) MBPA323 (A323),
wild-type preMBP (WT), MBP2261 (2261), MBPA57-145 (A57-145), MBPA2-26 (A2-26), and MBPA2-26/2261 (A&2-26/261) were synthesized
in vitro for 15 min, using an S-100 fraction prepared from SecB-overproducing cells. The reaction products were precipitated with preimmune
rabbit serum (C), anti-SecB serum (B) or rabbit anti-MBP serum (M). The immune complexes were subsequently analyzed by SDS-PAGE
and autoradiography. Positions of the full-length MBP species are indicated by arrowheads. For all MBP species, note the presence of
truncated forms migrating below the full-length protein that represent translational intermediates. (B) For lanes 1 to 3, MBPA323 was
synthesized in the absence of SecB, using an S-100 fraction prepared from SecB- cells; for lanes 3 to 6, MBPR323 was synthesized by using
an S-100 fraction prepared from SecB-overproducing cells. After synthesis, the reaction products were precipitated in the presence of 10 ig
of purified SecB (35). The autoradiograph in panel C shows the in vitro reaction products used for each set of immunoprecipitation
experiments (presented in the same order, i.e., lane 1 shows the products encoded by plasmid pJF32 [MBPA323]; lane 2, shows those encoded
by plasmid pJF2 [wild-type preMBP], etc.). Note that MBPA57-145 migrates on SDS-PAGE identically to precursor ,B-lactamase that is
encoded by each of the plasmids listed in Table 1.
amounts of MBPA2-26/2261 were immunoprecipitated with
anti-SecB serum (20%). Also, a faster-migrating, truncated
form of MBPA2-26 synthesized in the same reaction with
full-length MBPA2-26 was efficiently precipitated by anti-
SecB serum. Similar results were observed for truncated
forms (probably representing nascent chains) of other MBP
species synthesized in vitro.
In a separate experiment, we compared the ability of
anti-SecB serum to precipitate either preMBP+ or wild-type
precursor ribose-binding protein (preRBP+) synthesized in
vitro by using an S-100 fraction prepared from SecB-over-
producing cells. RBP export in vivo is known to be SecB
independent (5, 19). Approximately 8% of preMBP+ was
precipitated by anti-SecB serum (Fig. 2), whereas immuno-
precipitation of preRBP+ was not detectable.
We also synthesized preMBP+, MBPA323, MBPA2-26,
and preRBP+ in vitro in the presence of a significantly lower
concentration of SecB by using an S-100 fraction prepared
from a haploid secB+ strain (35). The amounts of preMBP+
and MBPA-323 precipitated by anti-SecB serum were both
lower than the amount obtained with an S-100 fraction from
SecB-overproducing cells (21 and 2% specifically precip-
itated, respectively) (Fig. 3). However, in this instance it
was also apparent that MBPA323 was much more efficiently
precipitated than was preMBP+. Once again, specific pre-
cipitation of MBPA2-26 and preRBP+ by anti-SecB serum
was not detected. In addition, specific precipitation of trun-
cated forms of both wild-type preMBP and MBPA2-26 by
anti-SecB serum was evident.
SecB does not complex with preMBP+ when added post-
translationally. After in vitro synthesis in the absence of
membranes, preMBP+ will fold into a stable, tertiary struc-
ture, as monitored by the acquisition of proteinase K resis-
tance. The rate of folding of wild-type preMBP is accelerated
when SecB is absent and greatly retarded when excess SecB
is present (5). Thus, the ability of MBP synthesized in vitro
to form a complex with SecB that was presented posttrans-
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FIG. 2. Demonstration that precursor RBP is not precipitated
with anti-SecB serum. Wild-type preMBP (first two lanes) and
wild-type preRBP (second two lanes) were synthesized in vitro for
15 min, using an S-100 fraction prepared from SecB-overproducing
cells. The reaction products were precipitated with preimmune
rabbit serum (lanes C) or rabbit anti-SecB serum (lanes B) and then
analyzed by SDS-PAGE and autoradiography. Positions of the
full-length preMBP and preRBP species are indicated by arrows at
the right and arrowheads at the left. Lanes 1 and 2 represent the in
vitro reaction products for plasmid pJF2 (wild-type preMBP) and
pAI12 (wild-type preRBP). It is important to note that plasmid
pAI12 does not encode P-lactamase, which migrates almost at the
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FIG. 3. SecB-MBP complex formation obtained by using an
S-100 fraction prepared from haploid secB+ cells. MBPA323 (A323),
wild-type preMBP (WT), MBPA2-26 (A2-26), and preRBP were
synthesized in vitro for 15 min, using an S-100 fraction prepared
from haploid secB+ cells. The reaction products were precipitated
with preimmune rabbit serum (lanes C) or anti-SecB serum (lanes B)
and then analyzed by SDS-PAGE and autoradiography. Positions of
the full-length MBP species are indicated by arrows. The total
products for each in vitro reaction are shown at the right. For each
of the MBP species, note the presence of truncated forms migrating
below the full-length proteins that represent translational interme-
diates.
lationally was assessed. MBPA323, preMBP+, and MBPA2-
26 were synthesized in the absence of SecB, protein synthe-
sis was terminated, and then purified' SecB protein (35) was
added to the reaction mixture. A substantial portion (19%) of
the MBPA323 formed a complex with SecB, as indicated by
immunoprecipitation with anti-SecB serum (Fig. 4). In
marked contrast, specific immunoprecipitation of preMBP+
or MBPA2-26 with anti-SecB serum was not detected when
SecB was added' posttranslationally. When preMBP+ was
first denatured in 5 M urea and subsequently diluted out of
urea in the presence of SecB, we were once again able to
detect a SecB-preMBP complex by immunoprecipitation
with anti-SecB serum (10%) (Fig. 4). Urea denaturation had
no effect on the ability ofMBPA323 to form a stable complex
with SecB. MBPA2-26 did not form an immunoprecipitable




The formation of complexes between SecB and wild-type
preMBP or various mutant MBP species synthesized in vitro
has been investigated by precipitating SecB-MBP complexes
with anti-SecB serum. The binding of SecB to MBP was
found not to be dependent on the signal peptide per se.
However, as particularly evidenced by marked differences in
our ability to demonstrate complex formation between SecB
and various MBP species, the stability of the SecB-MBP
complex under our experimental conditions was clearly
influenced by the folding properties of the MBP. The latter,
in turn, is clearly dependent on the presence or absence of
the signal peptide (24, 25, 27, 34; see below).
The role of folding in the stability of SecB-MBP com-
plexes was first indicated by the finding' that mutational
alterations in the mature moiety of preMBP (MBPA323,
MBPA57-145, and MBP2261) resulted in a significant in-
crease in the efficiently with which MBP was immunopre-
cipitated by anti-SecB serum. The single amino acid altera-
tion in MBP2261 has previously been shown to significantly
slow the folding of both the purified mature and precursor
forms of this protein (24). For MBPA323 and MBPA57-145,
the deletion of a large number of residues would certainly be
expected to significantly alter the folding properties of these
proteins. In fact, these two MBP specie's are unable to form
the tertiary structure characteristic of wild-type MBP, as
indicated by their sensitivity to proteinase K (12) and their
marked in vivo instability (5). It seems highly likely that the
lack of wi'ld-type folding properties facilitated the more
stable interaction of these three mutant MBP species with
SecB. MBPA57-145 and MBP2261, both of which are syn-
thesized with an intact MBP signal peptide, are exported to
the periplasm of cells with wild-type kinetics, and MBP2261
also can facilitate maltose uptake (5, 7). Therefore, these
altered MBPs would be expected to interact normally with
the protein export machinery. It is interesting that their
export in vivo is significantly less SecB dependent than is
that of wild-type MBP (5). In vitro studies have demon-
strated that preMBP+ rapidly becomes incompetent for
posttranslational translocation into inverted cytoplasmic
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FIG. 4. Demonstration that SecB does not form a complex with wild-type preMBP when added posttranslationally. Wild-type preMBP
(WT), MBPA323 (A323), and MBPA2-26 (A2-26) were synthesized in vitro, using an S-100 fraction prepared from SecB- cells. After 15 min,
protein synthesis was terminated. The incubations were continued for 5 min at 37°C, and then either 8 p.g of purified SecB was added to the
25-4ul reaction or the sample was denatured with urea. Urea was added to a final concentration of 5 M, the sample was incubated at room
temperature for 30 min, and then the sample was diluted fivefold into buffer containing either purified SecB or bovine serum albumin. After
10 min of incubation at 4°C with the SecB, the reaction products were immunoprecipitated with preimmune serum (lanes C), anti-SecB serum
(lanes B), or anti-MBP serum (lanes 1 to 3) and analyzed by SDS-PAGE and autoradiography. Positions of preMBP, MBPA323, and
MBPA2-26 are indicated by arrowheads.





membrane vesicles, whereas both MBPA57-145 and
MBP2261 remain competent for significantly longer periods
(34). Each of these properties is thought to be due to the
altered folding character of the mutant proteins, compared
with that of preMBP+, as is the finding that these two
proteins form a more stable complex with SecB than does
preMBP+.
Although only a small fraction of preMBP+ synthesized in
vitro could be demonstrated to complex with SecB by
immunoprecipitation with anti-SecB serum, our previous
studies monitoring the effect of SecB on preMBP+ folding in
vitro indicated that this interaction is more likely to include
virtually 100% of the preMBP molecules (5, 35). However,
preMBP+ folding was monitored in the presence of a great
excess of SecB. The equilibrium of the SecB-preMBP+
association must be determined in part by the molar ratio of
SecB to MBP and in part by the propensity of MBP species
to assume a conformation that cannot maintain this interac-
tion. We found that when haploid levels of SecB were
present, less complex was detected with MBP than in the
presence of excess SecB. Furthermore, Liu et al. (25)
recently reported that the molar ratio of purified SecB to
purified mature MBP2261 must be equal to or greater than 4
in order for SecB to effectively retard the folding of this MBP
species. Once excess SecB is complexed with antibody,
preMBP+ folding probably results in dissociation of the
great majority of SecB-preMBP complexes. Because of the
altered folding properties of MBPA323, MBPA57-145, and
MBP2261, they do not as readily assume a conformation that
disrupts or prevents the interaction with SecB. Thus, these
MBP species were precipitated with much greater efficiency
by anti-SecB serum. The failure to recover closer to 100% of
the latter proteins as complexes with SecB may indicate that
these MBP species still have some capacity to assume a
structure that is unable to stably interact with SecB. This
view is consistent with an earlier finding that both MBPA57-
145 and MBP2261 eventually lose competence for posttrans-
lational import into vesicles in vitro, although at a markedly
slower rate than does preMBP+ (35).
The correlation between the stability of the SecB-MBP
complex and the folding properties of the MBP was further
demonstrated by our finding that an interaction between
SecB and preMBP+ was detectable only when SecB was
present during MBP synthesis or when preMBP+ than had
been synthesized in the absence of SecB was denatured and
subsequently diluted out of denaturant in the presence of
SecB. Results similar to the latter have been described for
the interaction of trigger factor and the export-competent
form of purified proOmpA in vitro (8, 10). It would seem that
prior folding of preMBP+ prevents a stable interaction with
SecB, whereas an MBP species such as MBPA323 with its
altered folding properties can be shown to interact nearly as
well with SecB added 5 min after translation termination.
Our earlier studies indicated that SecB has as antifolding
activity but is unable to unfold preMBP+ that had previously
assumed a protease-resistant conformation (5, 35).
MBPA2-26 is also a mutant MBP species that exhibits
folding kinetics that are different from those of the wild-type
preMBP. When this protein lacking the signal peptide is
synthesized in vitro, it folds into a stable, protease-resistant
conformation at a rate far exceeding that of preMBP+ (34), a
finding consistent with the results of Park et al. (27), who
demonstrated that the presence of the signal peptide signif-
icantly retards the refolding of denatured, purified MBP. We
were unable to detect an interaction between SecB and
MBPA2-26, even after the latter had been denatured and
diluted in the presence of SecB. Although these results could
be interpreted to indicate that the signal peptide was re-
quired for an interaction with SecB, such an interaction was
clearly demonstrated with MBPA2-26/2261 harboring an
additional alteration that slows folding of the mature MBP
or, alternatively, a truncated form of MBPA2-26 that was a
by-product of the in vitro synthesis reaction. Liu et al. (25)
found that purified SecB is able to slow the folding of
purified, denatured mature MBP+ (= MBPA2-26), but only
if SecB was present in great molar excess and the tempera-
ture of the renaturation reaction was reduced from 25 to 5°C.
Thus, it appears that it is the particularly strong propensity
of MBPA2-26 to assume its final tertiary conformation that
prevents the formation of a stable, immunoprecipitable
complex with SecB.
The failure to, detect a complex between SecB and
MBPA2-26 in vitro also supports data obtained from in vivo
studies. We had previously demonstrated that the synthesis
of export-defective MBP species such as MBPA323 mark-
edly interferes with the export of SecB-dependent proteins
in E. coli cells. This interference is relieved in cells overex-
pressing SecB, leading to the conclusion that MBPA323
obstructs normal protein export in haploid secB+ cells by
binding for an extended period of time the small amount of
available SecB (5). In marked contrast, synthesis of
MBPA2-26 does not interfere with normal protein export in
vivo (25; J. W. Puziss and P. J. Bassford, Jr., unpublished
observations). This is despite the fact that this protein
species retains the site between residues 151 and 186 of the
mature moiety that was shown to be sufficient for mediating
this interference phenomenon (5). Presumably, stable bind-
ing of SecB to this region of MBPA2-26 is prevented by the
rapid folding of the protein.
The finding that the interaction between SecB and
preMBP+ is relatively unstable is not inconsistent with the
antifolding role proposed for SecB in promoting MBP ex-
port. By necessity, the interaction of SecB with preMBP
must be a transient one, since under normal circumstances
newly synthesized preMBP is rapidly secreted into the
periplasm. We have previously suggested that SecB func-
tions to retard, rather than prevent, the folding of preMBP
(5, 35), and in vivo studies have shown that preMBP+ whose
export is blocked does fold into a stable conformation in the
cytoplasm of SecB+ cells (28). A very stable interaction
between SecB and preMBP+ would probably be strongly
inhibitory to the export process. In fact, the export kinetics
of wild-type MBP in SecB-overproducing cells are some-
what slower than those exhibited in haploid secB+ cells (5S
20).
In a recent series of articles, Watanabe and Blobel (31-33)
reported that SecB is a component of a previously charac-
terized cytosolic export factor for preprotein import into
inverted E. coli membrane vesicles in vitro. Most recently,
they concluded that SecB binds to the signal peptide of a
truncated MBP species and functions as a procaryotic equiv-
alent of signal recognition particle (33). They were unable to
demonstrate an interaction of SecB with the mature MBP or
intact preMBP+. We previously had concluded that SecB
specifically interacted with the mature moiety of preMBP on
the basis of the interference phenomenon described above
that depleted cells of SecB, as well as the fact that alterations
in the mature MBP moiety reduced the SecB dependence of
the MBP for export (5). Gannon et al. (16) also concluded
that it was the mature moiety of preMBP+ that rendered this
protein SecB dependent, and as mentioned above, Liu et al.
(25) demonstrated that purified SecB could interact with
VOL. 172, 1990
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either purified mMBP+ or mMBP2261 to retard folding. The
experiments in this study demonstrated that SecB can spe-
cifically interact with MBP species from which the MBP
signal peptide has been largely (MBPA323) or completely
(MBPA2-26/2261) deleted. Furthermore, the interaction of
SecB with MBP is not noticeably improved for those MBP
species that retain the intact signal peptide (preMBP+,
preMBP2261, and preMBPA57-145). In fact, the association
of SecB with preMBP+ having an intact signal peptide was
significantly less than its association with MBPA2-26/2261
lacking a signal peptide. It has been suggested that hydro-
phobicity may be one important element in binding of SecB
to precursor proteins (23), so some interaction of SecB with
the MBP signal peptide as assayed by Watanabe and Blobel
(33) might not be unexpected. This question clearly requires
additional investigation.
Finally, since various proteins are exported in a SecB-
independent manner (e.g., RBP), does this mean that SecB
does not interact with these proteins? We found that
preRBP+ was not specifically precipitated by anti-SecB
serum. Furthermore, export-defective preRBP does not in-
terfere with normal protein export in vivo (D. N. Collier, S.
M. Strobel, and P. J. Bassford, Jr., unpublished data). These
results suggest that there is some specificity to the interac-
tion of SecB with precursor proteins. This view is also
consistent with the data of Collier et al. (5) that identified a
specific region of the mature MBP that interacted with SecB.
On the other hand, Kumamoto (18) reported that some RBP
synthesized in vivo could be bound to an anti-SecB affinity
column. The interaction of SecB with preRBP species ex-
hibiting altered folding properties, now under way in this
laboratory, may provide additional insight into this question.
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